Symptomatic, Presymptomatic, and Asymptomatic Transmission of SARS-CoV-2

Steven J. Krieg, Jennifer J. Schnur, Marie Lynn Miranda, Michael E. Pfrender, Nitesh V. ChawlamedRxiv 2021 · DOI

Abstract

Importance: Asymptomatic and presymptomatic carriers of SARS-CoV-2 are an ongoing and significant risk for community spread of the virus, especially with the majority of the world still unvaccinated and new variants emerging. Objective: To quantify the presence and effects of symptom presentation (or lack thereof) on the community transmission of SARS-CoV-2. Design: A cohort of 12,960 young adults participated in health reporting, contact tracing, and COVID-19 testing for 103 days between August 10 and November 20, 2020. Setting: A mid-sized university campus in Indiana, United States. Participants: University students, most of whom are 18-23 years old (67%) and living in congregate on-campus housing (60%). Of the 12,960 students, 1,556 (12.0%) tested positive for COVID-19 during the 103 day period. Of the positive cases, 1,198 reported sufficient health check data (7 days prior and 7 days post diagnosis) to be classified as asymptomatic or symptomatic. Main Outcome: Secondary attack rate (SAR), based on presentation or absence of symptoms and type of symptoms calculated with respect to confirmed close contacts and a 14-day incubation period. Results: 32.5% of all cases reported no symptoms within a 15-day window centered on their positive test. The SAR of asymptomatic COVID-19 index cases was 19.1%. The SAR of symptomatic index cases was 25.4%, and while the onset timing of symptoms did not affect transmission, the presence of certain symptoms like fever, shortness of breath, and dry cough increased the SAR as high as 30.0%. Conclusions and Relevance: Asymptomatic rates of transmission of SARS-CoV-2 are much higher than has been estimated in prior studies and continue to pose a significant and ongoing risk in the pandemic.

Introduction

Early in the COVID-19 pandemic, it became evident that individuals without symptoms could spread the virus. However, accurately quantifying this risk proved difficult. Previous research offered a wide range for the proportion of asymptomatic cases—anywhere from 40% to 76%—and frequently failed to distinguish between "true" asymptomatic cases (those who never develop symptoms) and "presymptomatic" cases (those who test positive before symptoms appear).

Without high-fidelity, longitudinal data, public health officials struggled to model the impact of asymptomatic spread or determine the effectiveness of symptom-based screening, such as the daily health checks required by many institutions. This study, conducted at the University of Notre Dame, addresses this gap by tracking a large, closed cohort of nearly 13,000 students with daily reporting, providing a high-resolution look at how SARS-CoV-2 moves through a young, congregate population.

Methods

The researchers followed a cohort of 12,960 students over a 103-day period during the Fall 2020 semester. The study integrated several data streams:

  • Daily Health Checks: Students used an electronic survey to report the presence of 11 specific symptoms.
  • Comprehensive Testing: The university employed a mix of symptomatic testing (Antigen + PCR) and mandatory random surveillance testing.
  • Contact Tracing: Manual tracers identified close contacts for every positive case.
  • The 15-Day Window: To accurately classify cases, the authors analyzed symptom reports from 7 days before to 7 days after a positive test. A "true asymptomatic" case required zero symptoms across this entire 15-day period.
  • Secondary Attack Rate (SAR): This was calculated as the proportion of susceptible close contacts who tested positive within a 14-day incubation period following exposure to an index case.

Of the 1,556 students who tested positive, 1,198 provided sufficient longitudinal data for classification. The study recorded 3,736 close contacts and over 868,000 individual daily health checks.

Secondary Attack Rates

A primary finding of the study is that "silent" transmission is far more efficient than previously estimated. The secondary attack rate for asymptomatic cases was 19.1%, which is only about 25% lower than the symptomatic SAR of 25.4%. This contradicts earlier meta-analyses that suggested asymptomatic transmission was negligible.

Secondary attack rates for asymptomatic and symptomatic index cases over a 14-day incubation period.

Furthermore, the data revealed the ineffectiveness of entry-point symptom checks. A striking 75.2% of positive cases reported no symptoms on the day of their positive test. Even two days after testing positive, over half (50.2%) remained asymptomatic. This highlights why temperature or symptom checks at building entrances often fail to catch active spreaders.

The Impact of Specific Symptoms

Not all symptoms correlate equally with transmission risk. The study identified "symptom super-spreaders" where the presence of fever, shortness of breath, or a dry cough increased the SAR to approximately 30.0%. These respiratory-heavy symptoms likely boost viral shedding significantly.

Secondary attack rates categorized by the presence or absence of specific reported symptoms.

Conversely, an "anosmia paradox" was observed: cases reporting a loss of taste or smell, or diarrhea, actually showed lower transmission rates than those without those symptoms. This could be due to behavioral factors—students with these "classic" COVID-19 symptoms might isolate more strictly—or biological differences in viral load and shedding routes.

Conclusion

This longitudinal study demonstrates that asymptomatic prevalence is high (32.5% of cases) and that these individuals transmit the virus at robust rates. The findings suggest that daily symptom checks are an unreliable primary defense against community spread. Given the high rate of asymptomatic transmission and the varying impact of specific symptoms, a broader embrace of masking, social distancing, and surveillance testing is necessary to counter the spread of SARS-CoV-2.

The study's limitations include a relatively homogeneous population of young, healthy students and data collected prior to the dominance of the Delta and Omicron variants. Future research should apply this longitudinal "window" approach to newer variants and vaccinated populations to understand how the dynamics of asymptomatic spread continue to evolve.

Summary updated

Abstract

ABSTRACT Importance Asymptomatic and presymptomatic carriers of SARS-CoV-2 are an ongoing and significant risk for community spread of the virus, especially with the majority of the world still unvaccinated and new variants emerging. Objective To quantify the presence and effects of symptom presentation (or lack thereof) on the community transmission of SARS-CoV-2. Design A cohort of 12,960 young adults participated in health reporting, contact tracing, and COVID-19 testing for 103 days between August 10 and November 20, 2020. Setting A mid-sized university campus in Indiana, United States. Participants University students, most of whom are 18-23 years old (67%) and living in congregate on-campus housing (60%). Of the 12,960 students, 1,556 (12.0%) tested positive for COVID-19 during the 103 day period. Of the positive cases, 1,198 reported sufficient health check data (7 days prior and 7 days post diagnosis) to be classified as asymptomatic or symptomatic. Main Outcome Secondary attack rate, based on presentation or absence of symptoms and type of symptoms calculated with respect to confirmed close contacts and a 14-day incubation period, varies on the type of symptom, timing of symptoms, and absence of symptoms. A quantifiable understanding of SAR on the longitudinal data of more than one thousand subjects in a university environment provides keen insights about developing strategies to respond to the continued prevalence of COVID-19 in the unvaccinated world and growth of variants. Results 32.5% of all cases reported no symptoms within a 15-day window centered on their positive test (7 days prior, the day of the positive test, and 7 days after). The secondary attack rate (SAR) of asymptomatic COVID-19 index cases was 19.1%. The SAR of symptomatic index cases was 25.4%, and while the onset timing of symptoms did not affect transmission, the presence of certain symptoms like fever, shortness of breath, and dry cough increased the SAR as high as 30.0%. Conclusions and Relevance Asymptomatic rates of transmission of SARS-CoV-2 are much higher than has been estimated in prior studies and continue to pose a significant and ongoing risk in the pandemic, especially with the prevalence of variants like the Delta variant. In addition, different symptoms are associated with varying rates of transmission, posing a significant challenge in how to diagnose or assess risk through mechanisms such as daily health checks for symptom reporting, a practice commonly in place for entry into schools, offices, restaurants, etc. Given the uncertain nature of symptoms and varied transmission rates, this study suggests a broader embrace of masking, social distancing and testing might be needed to counter the variants until higher global vaccination rates can be achieved.
BibTeX
@misc{krieg2021symptomatic,
  author = {Steven J. Krieg and Jennifer J. Schnur and Marie Lynn Miranda and Michael E. Pfrender and Nitesh V. Chawla},
  title = {{Symptomatic, Presymptomatic, and Asymptomatic Transmission of SARS-CoV-2}},
  year = {2021},
  doi = {10.1101/2021.07.08.21259871},
  howpublished = {medRxiv},
}
Figure